Berlin Cures Announces Formation of Scientific Advisory Board

ZUG, Switzerland, May 23, 2018 /PRNewswire/ -- Drug developer Berlin Cures today announced the formation of a Scientific Advisory Board (SAB) and the appointment of its first two members, Prof. Beda M. Stadler and Prof. Wilhelm Vetter, to help advance the clinical development of BC 007,...

from PR Newswire: https://ift.tt/2IGyjHM
via